Greg Tesch has a strong background in the fields of kidney disease and inflammation. In 1997, he completed a Ph.D. degree in nephrology research at Monash University, Melbourne, Australia, and commenced a 2-year postdoctoral fellowship at the Renal Division of the Harvard Medical School. During this time, he examined the mechanisms of inflammation in animal models of glomerulonephritis and lupus nephritis. In 1999, he took up a position as a Senior Research Officer at the Monash Medical Centre and studied novel therapeutic strategies for targeting inflammation in kidney disease. In 2001, he established a research group to specifically examine the mechanisms and consequences of inflammation in diabetic nephropathy. This has included studies of renal biopsies, cultured cells, and rodent models of type 1 and type 2 diabetic nephropathy. In 2006, Dr. Tesch received a Career Development Award to examine the mechanisms of inflammation in diabetes and diabetic nephropathy. Dr. Tesch is now the Head of the diabetes research group at the Nephrology Department at the Monash Medical Centre in Melbourne, Australia. He currently has 65 research publications and is a regular speaker on the topic of inflammation in diabetic nephropathy at national and international meetings.
Biography Updated on 25 October 2009